EFFECTS OF C-MYC EXPRESSION ON CELL-CYCLE PROGRESSION

被引:150
作者
HANSON, KD [1 ]
SHICHIRI, M [1 ]
FOLLANSBEE, MR [1 ]
SEDIVY, JM [1 ]
机构
[1] YALE UNIV,SCH MED,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06510
关键词
D O I
10.1128/MCB.14.9.5748
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We used targeted homologous recombination to disrupt one c-myc gene copy in a diploid fibroblast cell line and found that a twofold reduction in Myc expression resulted in loner exponential growth rates and a lengthening of the G(0)-to-S-phase transition (hi. Shichiri, Ii;. D. Hanson and J. hi. Sedivy, Cell Growth Differ. 4:93-104, 1993). Myc is a transcription factor, and the number of target genes whose regulation could result in differential growth rates may be very large. We have approached this problem by examining effects of reduced c-myc expression in three broad areas: (i) secretion of growth factors, (ii) expression of growth factor receptors, and (iii) intracellular signal transduction between Myc and components of the intrinsic cell cycle clock. We have found no evidence that differential medium conditioning can account for the growth phenotypes.. Likewise, the expression of receptors for platelet-derived growth factor, epidermal growth factor, basic fibroblast growth factor, and insulin-like growth factor I was the same in diploid and heterozygous cells (platelet-derived growth factor, epidermal growth factor, fibroblast growth factor, and insulin-like growth factor are the sole growth factors required by these cells for growth in serum-free medium). In contrast, expression of cyclin E, cyclin A, and Rb phosphorylation were delayed when quiescent c-myc heterozygous cells were stimulated to enter the cell cycle. Expression of cyclin D1, cyclin D3, and Cdk2 was not affected. The timing of cyclin E induction was the earliest observable effect of reduced Myc expression. Our data indicate that Myc contributes to regulation of proliferation by a cell-autonomous mechanism that involves the modulation of cyclin E expression and, consequently, progression through the restriction point of the cell cycle.
引用
收藏
页码:5748 / 5755
页数:8
相关论文
共 50 条
[31]   MYB AND MYC IN THE CELL-CYCLE [J].
BISHOP, JM ;
EILERS, M ;
KATZEN, AL ;
KORNBERG, T ;
RAMSAY, G ;
SCHIRM, S .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1991, 56 :99-107
[32]   C-MYC MESSENGER-RNA IS ELEVATED AS DIFFERENTIATING LENS CELLS WITHDRAW FROM THE CELL-CYCLE [J].
NATH, P ;
GETZENBERG, R ;
BEEBE, D ;
PALLANSCH, L ;
ZELENKA, P .
EXPERIMENTAL CELL RESEARCH, 1987, 169 (01) :215-222
[33]   Ecdysteroid promotes cell cycle progression in the Bombyx wing disc through activation of c-Myc [J].
Moriyama, Minoru ;
Osanai, Kohji ;
Ohyoshi, Tomokazu ;
Wang, Hua-Bing ;
Iwanaga, Masashi ;
Kawasaki, Hideki .
INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2016, 70 :1-9
[34]   Cardiomyocyte-specific overexpression of the oncogene c-Myc induces cell-cycle reentry and hypertrophic cardiomyopathy [J].
Lee, H. ;
Liner, A. ;
Richardson, S. ;
Lesnefsky, E. J. ;
Hoit, B. D. ;
Smith, M. A. .
JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (03) :637-638
[35]   Zwint facilitates melanoma progression by promoting c-Myc expression [J].
Mou, Kuanhou ;
Zhang, Jian ;
Mu, Xin ;
Wang, Lijuan ;
Liu, Wenli ;
Ge, Rui .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (02)
[36]   EFFECTS OF CHARTREUSIN ON CELL SURVIVAL AND CELL-CYCLE PROGRESSION [J].
BHUYAN, BK ;
ROBINSON, MI ;
SHUGARS, KD ;
BONO, VH ;
DION, RL .
CANCER RESEARCH, 1978, 38 (09) :2734-2739
[37]   SURVEY OF DRUG EFFECTS ON CELL-CYCLE PROGRESSION [J].
BONO, VH ;
DION, RL .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR) :122-122
[38]   EFFECTS OF ANTINEOPLASTIC AGENTS ON THE CELL-CYCLE PROGRESSION [J].
CHARCOSSET, JY .
BIOLOGY OF THE CELL, 1986, 58 (02) :135-138
[39]   Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug:: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells [J].
Serpe, L ;
Laurora, S ;
Pizzimenti, S ;
Ugazio, E ;
Ponti, R ;
Canaparo, R ;
Briatore, F ;
Barrera, G ;
Gasco, MR ;
Bernengo, MG ;
Eandi, M ;
Zara, GP .
ANTI-CANCER DRUGS, 2004, 15 (05) :525-536
[40]   CONTENT OF C-MYC ONCOGENE P62 PROTEIN DURING THE CELL-CYCLE OF MAST-CELL LINES [J].
DIVINCI, A ;
MINKS, M ;
BRUNO, S ;
GEIDO, E ;
GIARETTI, W .
BASIC AND APPLIED HISTOCHEMISTRY, 1988, 32 (03) :351-351